Rankings
▼
Calendar
PLRX FY 2023 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
PLRX
Pliant Therapeutics, Inc.
$85M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
-83.7% YoY
Gross Profit
$2M
100.0% margin
Operating Income
-$184M
-11654.7% margin
Net Income
-$161M
-10211.1% margin
EPS (Diluted)
$-2.75
Cash Flow
Operating Cash Flow
-$116M
Free Cash Flow
-$117M
Stock-Based Comp.
$44M
Balance Sheet
Total Assets
$512M
Total Liabilities
$39M
Stockholders' Equity
$474M
Cash & Equivalents
$63M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$10M
-83.7%
Gross Profit
$2M
$10M
-83.7%
Operating Income
-$184M
-$127M
-44.8%
Net Income
-$161M
-$123M
-30.8%
← Q4 2022
All Quarters
Q1 2023 →